Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Meningioma 7 Brain Neoplasms 6 Leukemia, Myeloid, Acute 5 Head and Neck Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 3 Glioblastoma 3 Stomach Neoplasms 2 Myeloproliferative Disorders 2 Myelodysplastic Syndromes 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia 2 Laryngeal Neoplasms 2 Gliosarcoma 2 Esophageal Neoplasms 2 Central Nervous System Neoplasms 2 Thyroid Carcinoma, Anaplastic 1 Thrombocytosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pharyngeal Neoplasms 1 Paranasal Sinus Neoplasms 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Nose Neoplasms 1 Nasopharyngeal Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1

Interventions

Imatinib Mesylate 2 telapristone acetate 1 Specimen Handling 1 Sirolimus 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Hydroxyurea 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Fibroma × Hydroxyurea × Clear all

NCT00978146 2017-04-20

Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors

Children's Hospital of Philadelphia

Phase 2 Withdrawn

Fibroma, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡